Yasho Industries doubles FY27 capex to ₹250 crore
pre-market1 source ↓machine-written, see hownot a recommendation
- ₹250 crore FY27 capex
Yasho Industries reported a sharp improvement in consolidated profitability for Q1FY27, with net profit rising 890% year on year to ₹36.05 crore. The company also doubled its capital expenditure plan for FY27 to ₹250 crore, citing 42% volume growth and firm enquiries from international customers. The board approved the unaudited results on 31 Jul 2026, while statutory auditors issued an unmodified review conclusion.
The higher investment signals that management is expanding capacity and capabilities ahead of a stronger demand cycle in specialty chemicals 🧪. The company said international enquiries include a significant contract with a multinational corporation, although the contract value and implementation timeline were not disclosed. The investment programme is linked to a revised FY28 revenue target of over ₹1,600 crore, making execution and capacity utilisation important factors for the chemicals business.
Key points:
• ₹250 crore FY27 capex: The outlay was doubled from the earlier plan, increasing the company’s near-term focus on expansion and project execution.
• Net profit ₹36.05 crore: Q1FY27 profit increased 890% year on year, marking a sharp turnaround in reported profitability.
• Volume growth 42%: Higher volumes and international customer enquiries supported the company’s confidence in sustained demand recovery.
The capex announcement matters because stronger volumes can improve operating leverage if the new investments are commissioned on schedule and matched by customer demand. It also raises the importance of funding requirements, project milestones and the pace at which additional capacity contributes to revenue. For the broader specialty-chemicals segment, sustained export enquiries and multinational customer contracts remain key indicators of demand visibility 🌍.
The next developments to watch are the company’s subsequent quarterly results, progress on the ₹250 crore investment programme, details on the MNC contract and evidence that the FY28 revenue target of more than ₹1,600 crore is supported by realised orders. The company’s disclosure also follows its Q1FY27 results announcement and regulatory filing under the SEBI listing regulations.
Source: scanx.trade, 10 Oct 2026
Not investment advice. For informational purposes only.